This book includes seven chapters from internationally recognized experts with specialist knowledge of non small cell lung cancer. It focuses on major biological targets and pathways implicated in the development of NSCLC and the associated classes of therapy that have been developed, evaluated and utilized in the clinic. The authors also provide information on ongoing clinical trials evaluating promising drugs in the developmental pipeline.
